Aridis Pharmaceuticals: Hasan Jafri, CMO
Aridis Pharmaceuticals has appointed Hasan Jafri as its new chief medical officer. He replaces interim CMO Paul Mendelman, who will transition to the role of senior medical advisor.
Jafri most recently worked for AstraZeneca, where he served as senior medical director, clinical research and development, microbial sciences, clinical head of Antibacterial mAb Program, and coordinator of the European Public-Private COMBACTE-NET & COMBACTE-MAGNET consortia.
"I'm excited to join Aridis especially at such a critical time within the infectious disease arena given the COVID-19 pandemic, the global antibiotic resistance challenges and the need for new innovative antibacterial therapies," Jafri commented.